Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoclopramide versus ondansetron for preventing nausea and vomiting after cesarean section
IRCT20220502054722N1Phase 3Completed
- Sponsor
- Vice-Chancellery for Research, Hormozgan University of Medical Sciences
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in postoperative nausea and vomiting (PONV) comparing Metoclopramide with Ondansetron (2 arms). Started Aug 2022; status: completed.
02
Drugs
metoclopramideondansetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20220502054722N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220502054722N1.